All News

The US Food and Drug Administration approved the new drug application (NDA) for Merck’s investigational fertility treatment corifollitropin alfa. Merck is seeking approval for the use of corifollitropin alfa in controlled ovarian stimulation (COS). If approved, the drug would be the first sustained follicular stimulant available in the United States.

The findings of a recent study have shown that uterine fibroid tumors are more common and more severe in African American women compared with white women. Find out how you can better treat uterine fibroid tumors in this high-risk population.

In 2010, Medicaid financed 48% of all births in the United States, an increase of 19% in the proportion of all births covered by Medicaid in 2008. This finding, from a study published in the Sept. 2013 issue of the journal Women's Health Issues, adds to previous research showing that the numbers of women dependent on Medicaid for health care are growing.

Estrogen therapy is still the mainstay of therapy for moderate-to-severe symptoms and long-term studies on endometrial safety of local estrogen and ospemifene are lacking. Those are the key conclusions from an updated position statement on management of symptomatic vulvovaginal atrophy (VVA) in postmenopausal women issued by the North American Menopause Society (NAMS).

Umbilical cord prolapse

There is no evidence that UCP can be prevented, but rapid diagnosis and delivery have been shown to be advantageous. The authors present a plan to help you respond surely and swiftly.

ICD-10 and the ob/gyn

The transition to ICD-10 is looming. You'll be ready if you start planning now.

EHR benefits and costs

The Contemporary OB/GYN tech experts address the learning curve associated with an EHR adoption.

A recent study in Nursing Outlook suggests that women who are responsible for full-time care of their grandchildren may be at increased risk of developing depressive symptoms compared with their non-primary caregiver counterparts.

A screening protocol that takes into consideration CA-125 levels over time and results of transvaginal ultrasound (TVS) shows promise in early detection of ovarian cancer, according to a new report from investigators at the University of Texas MD Anderson Cancer Center. In a large, prospective study, the combination demonstrated excellent specificity and positive predictive value (PPV) in a group of women at average risk of ovarian cancer.

Enhanced recovery pathway (ERP) leads to earlier discharge, cost savings, better patient satisfaction, lower narcotic use, and more stable readmission rates in complex gynecologic surgery patients, according to a study recently published in Obstetrics & Gynecology.